# CP-690,550 Thorough QTc Study

> **NCT01743677** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CP-690,550
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01743677
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-26
- **Primary completion:** 2008-02-07
- **Final completion:** 2008-02-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743677, "CP-690,550 Thorough QTc Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01743677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*